Amyloid-β Metal Interaction and Metal Chelation

[1]  Xudong Huang,et al.  Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. , 2008, Journal of neurochemistry.

[2]  A. Mackinnon,et al.  Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. , 2003, Archives of neurology.

[3]  Gregory A. Hickey,et al.  Amyloid-β Antibody Treatment Leads to Rapid Normalization of Plaque-Induced Neuritic Alterations , 2003, The Journal of Neuroscience.

[4]  M. Daly,et al.  Genetic association of Alzheimer's disease with multiple polymorphisms in alpha-2-macroglobulin. , 2003, Human molecular genetics.

[5]  A. Cuello,et al.  The impact of Aβ-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice , 2003, Neuroscience.

[6]  D. Coulter,et al.  Clioquinol effects on tissue chelatable zinc in mice , 2003, Journal of Molecular Medicine.

[7]  T. Arendt,et al.  Degeneration of β-amyloid-associated cholinergic structures in transgenic APPSW mice , 2003, Brain Research.

[8]  D. Butterfield,et al.  Oxidative stress precedes fibrillar deposition of Alzheimer’s disease amyloid β-peptide (1–42) in a transgenic Caenorhabditis elegans model , 2003, Neurobiology of Aging.

[9]  G. Perry,et al.  Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease , 2003, Biometals.

[10]  Math P. Cuajungco,et al.  Zinc takes the center stage: its paradoxical role in Alzheimer’s disease , 2003, Brain Research Reviews.

[11]  C. Masters,et al.  Overexpression of Alzheimer's Disease Amyloid-β Opposes the Age-dependent Elevations of Brain Copper and Iron* , 2002, The Journal of Biological Chemistry.

[12]  P. Pasqualetti,et al.  Elevation of serum copper levels in Alzheimer’s disease , 2002, Neurology.

[13]  D. Butterfield,et al.  Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death , 2002, Neurobiology of Aging.

[14]  Carsten Schmidt,et al.  Evidence for a copper-binding superfamily of the amyloid precursor protein. , 2002, Biochemistry.

[15]  D. Butterfield,et al.  Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress , 2002 .

[16]  M. Catani,et al.  Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. , 2002, Archives of neurology.

[17]  Jae-Young Koh,et al.  Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  T. Ueda,et al.  Amyloid-β-protein (Aβ) (25–35)-associated free radical generation is strongly influenced by the aggregational state of the peptides , 2002 .

[19]  K. Blennow,et al.  Treatment of Alzheimer’s Disease with Clioquinol , 2001, Dementia and Geriatric Cognitive Disorders.

[20]  A. Takashima,et al.  New Insights on How Metals Disrupt Amyloid β-Aggregation and Their Effects on Amyloid-β Cytotoxicity* , 2001, The Journal of Biological Chemistry.

[21]  H. Takeuchi,et al.  Inhibitory effect of copper(II) on zinc(II)-induced aggregation of amyloid beta-peptide. , 2001, Biochemical and biophysical research communications.

[22]  G. H. Hoa,et al.  Zinc binding to Alzheimer's Abeta(1-16) peptide results in stable soluble complex. , 2001, Biochemical and biophysical research communications.

[23]  T. Ueda,et al.  The relationship between the aggregational state of the amyloid‐β peptides and free radical generation by the peptides , 2001, Journal of neurochemistry.

[24]  C. Masters,et al.  Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice , 2001, Neuron.

[25]  C. Masters,et al.  Alzheimer's Disease Amyloid-β Binds Copper and Zinc to Generate an Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like Subunits* , 2001, The Journal of Biological Chemistry.

[26]  G. Lees,et al.  Comparative effects of metal chelating agents on the neuronal cytotoxicity induced by copper (Cu+2), iron (Fe+3) and zinc in the hippocampus , 2001, Brain Research.

[27]  Ashley I. Bush,et al.  Redox-active iron mediates amyloid-β toxicity , 2001 .

[28]  M G McInnis,et al.  Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. , 2000, Science.

[29]  J. Blangero,et al.  Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. , 2000, Science.

[30]  Xudong Huang,et al.  Metal Chelation as a Potential Therapy for Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[31]  D. Westaway,et al.  Examining the zinc binding site of the amyloid-β peptide , 2000 .

[32]  Xudong Huang,et al.  Evidence that the β-Amyloid Plaques of Alzheimer's Disease Represent the Redox-silencing and Entombment of Aβ by Zinc* , 2000, The Journal of Biological Chemistry.

[33]  G. Multhaup,et al.  Differential effects of zinc on amyloid precursor protein (APP) processing in copper-resistant variants of cultured Chinese hamster ovary cells. , 2000, Cellular and molecular biology.

[34]  R. Tanzi,et al.  Copper catalyzed oxidation of Alzheimer Abeta. , 2000, Cellular and molecular biology.

[35]  H. Takeuchi,et al.  Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes. , 2000, Biochemistry.

[36]  R. Tanzi,et al.  Alzheimer's disease, beta-amyloid protein and zinc. , 2000, The Journal of nutrition.

[37]  Sang Won Suh,et al.  Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains , 2000, Brain Research.

[38]  Mark A. Smith,et al.  In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease , 2000, Journal of neurochemistry.

[39]  B. Kagan,et al.  Amyloid peptide channels: Blockade by zinc and inhibition by Congo red (amyloid channel block) , 2000, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[40]  C. Masters,et al.  Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. , 1999, The Journal of biological chemistry.

[41]  C. Masters,et al.  Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion. , 1999, The Biochemical journal.

[42]  C. Masters,et al.  The Alzheimer's Disease Amyloid Precursor Protein Modulates Copper-Induced Toxicity and Oxidative Stress in Primary Neuronal Cultures , 1999, The Journal of Neuroscience.

[43]  D. Butterfield,et al.  In Vitro and in vivo Protein Oxidation Induced by Alzheimer's Disease Amyloid β‐Peptide (1–42) , 1999, Annals of the New York Academy of Sciences.

[44]  N. Inestrosa,et al.  Cysteine 144 Is a Key Residue in the Copper Reduction by the β‐Amyloid Precursor Protein , 1999, Journal of neurochemistry.

[45]  C. Masters,et al.  Aqueous Dissolution of Alzheimer’s Disease Aβ Amyloid Deposits by Biometal Depletion* , 1999, The Journal of Biological Chemistry.

[46]  C. Glabe,et al.  Binding of Zn(II), Cu(II), and Fe(II) ions to Alzheimer's A beta peptide studied by fluorescence. , 1999, Bioorganic & medicinal chemistry letters.

[47]  Arroyo,et al.  Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers* , 1999, European journal of clinical investigation.

[48]  C. Barrow,et al.  Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer's disease. , 1999, Biochemistry.

[49]  Jae-Young Koh,et al.  Histochemically Reactive Zinc in Plaques of the Swedish Mutant β-Amyloid Precursor Protein Transgenic Mice , 1999, The Journal of Neuroscience.

[50]  Xudong Huang,et al.  The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. , 1999, Biochemistry.

[51]  R. Tanzi,et al.  Differential effects of apolipoprotein E isoforms on metal-induced aggregation of A beta using physiological concentrations. , 1999, Biochemistry.

[52]  Steven M. Horvath,et al.  Alpha-2 macroglobulin is genetically associated with Alzheimer disease , 1998, Nature Genetics.

[53]  G. Lees,et al.  Diverse effects of metal chelating agents on the neuronal cytotoxicity of zinc in the hippocampus , 1998, Brain Research.

[54]  G. Lees,et al.  Effect of metal chelating agents on the direct and seizure-related neuronal death induced by zinc and kainic acid , 1998, Brain Research.

[55]  T. Bird,et al.  Recent Advances in the Genetics of Alzheimer's Disease , 1998, Journal of geriatric psychiatry and neurology.

[56]  J. D. Robertson,et al.  Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.

[57]  W. D. Ehmann,et al.  Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. , 1998, Neurotoxicology.

[58]  Xudong Huang,et al.  Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis* , 1998, The Journal of Biological Chemistry.

[59]  M. Tabaton,et al.  Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress , 1998, Journal of neurochemistry.

[60]  C. Masters,et al.  Copper-binding amyloid precursor protein undergoes a site-specific fragmentation in the reduction of hydrogen peroxide. , 1998, Biochemistry.

[61]  J. Connor,et al.  Abnormal localization of iron regulatory protein in Alzheimer's disease , 1998, Brain Research.

[62]  S D Rogers,et al.  Fibrillar b-Amyloid Induces Microglial Phagocytosis , Expression of Inducible Nitric Oxide Synthase , and Loss of a Select Population of Neurons in the Rat CNS In Vivo , 1998 .

[63]  Xudong Huang,et al.  Zinc-induced Alzheimer’s Aβ1–40 Aggregation Is Mediated by Conformational Factors* , 1997, The Journal of Biological Chemistry.

[64]  G. Perry,et al.  Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[65]  K. Rhodes,et al.  Selective Aggregation of Endogenous β‐Amyloid Peptide and Soluble Amyloid Precursor Protein in Cerebrospinal Fluid by Zinc , 1997, Journal of neurochemistry.

[66]  P Woodbury,et al.  A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. , 1997, The New England journal of medicine.

[67]  W. D. Ehmann,et al.  Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress , 1996, Journal of the Neurological Sciences.

[68]  R. Tanzi,et al.  REVIEWThe Gene Defects Responsible for Familial Alzheimer's Disease , 1996, Neurobiology of Disease.

[69]  G. Lees,et al.  Prevention of zinc neurotoxicity in vivo by N,N,N',N'-tetrakis (2-pyridylmethyl) ethylene-diamine (TPEN). , 1996, Neuroreport.

[70]  M. Baudry,et al.  beta-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[71]  C. Masters,et al.  The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I) , 1996, Science.

[72]  D. Selkoe,et al.  Sequence of Deposition of Heterogeneous Amyloid β-Peptides and APO E in Down Syndrome: Implications for Initial Events in Amyloid Plaque Formation , 1996, Neurobiology of Disease.

[73]  W. Markesbery,et al.  Serum zinc, senile plaques, and neurofibrillary tangles: findings from the Nun Study. , 1995, Neuroreport.

[74]  D. Schubert,et al.  The role of iron in beta amyloid toxicity. , 1995, Biochemical and biophysical research communications.

[75]  G. Schellenberg,et al.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.

[76]  C. Masters,et al.  Characterization of the high affinity heparin binding site of the Alzheimer's disease βA4 amyloid precursor protein (APP) and its enhancement by zinc(II) , 1995, Journal of molecular recognition : JMR.

[77]  C. Masters,et al.  Proteolytic Processing of Alzheimer's Disease βA4 Amyloid Precursor Protein in Human Platelets (*) , 1995, The Journal of Biological Chemistry.

[78]  W. D. Ehmann,et al.  Elemental imbalances in the olfactory pathway in Alzheimer's disease , 1995, Journal of the Neurological Sciences.

[79]  M. Pericak-Vance,et al.  Apolipoprotein E E4 allele and risk of dementia. , 1995, JAMA.

[80]  B. Yankner,et al.  Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[81]  C. Masters,et al.  Interaction between the zinc(II) and the heparin binding site of the Alzheimer's disease βA4 amyloid precursor protein (APP) , 1994, FEBS letters.

[82]  Patrizia Mecocci,et al.  Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease , 1994, Annals of neurology.

[83]  R. Tanzi,et al.  The amyloid beta-protein precursor and its mammalian homologues. Evidence for a zinc-modulated heparin-binding superfamily. , 1994, The Journal of biological chemistry.

[84]  C. Masters,et al.  Rapid induction of Alzheimer A beta amyloid formation by zinc. , 1994, Science.

[85]  C. Masters,et al.  The βA4 amyloid precursor protein binding to copper , 1994 .

[86]  C. Behl,et al.  Hydrogen peroxide mediates amyloid β protein toxicity , 1994, Cell.

[87]  B. Hyman,et al.  Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid β protein precursor , 1993, Nature Genetics.

[88]  C. Masters,et al.  A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease. , 1993, The Journal of biological chemistry.

[89]  D. Selkoe,et al.  Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production , 1992, Nature.

[90]  R. Tanzi,et al.  Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[91]  Barry Halliwell,et al.  Reactive Oxygen Species and the Central Nervous System , 1992, Journal of neurochemistry.

[92]  M. Beal,et al.  In vivo neurotoxicity of beta-amyloid [β(1–40)] and the β(25–35) fragment , 1992, Neurobiology of Aging.

[93]  C. Geula,et al.  The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected β-amyloid in the rat brain , 1992, Neurobiology of Aging.

[94]  J. Connor,et al.  A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains , 1992, Journal of neuroscience research.

[95]  Carl W. Cotman,et al.  In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity , 1991, Brain Research.

[96]  D. Price,et al.  Neurofibrillary tangles and β-amyloid deposits in Alzheimer's disease , 1991, Current Opinion in Neurobiology.

[97]  C. Cotman,et al.  Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. , 1991, European journal of pharmacology.

[98]  J. Constantinidis.  The hypothesis of zinc deficiency in the pathogenesis of neurofibrillary tangles. , 1991, Medical hypotheses.

[99]  D. McLachlan,et al.  Intramuscular desferrioxamine in patients with Alzheimer's disease , 1991, The Lancet.

[100]  L. Villa-komaroff,et al.  Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. , 1989, Science.

[101]  E. Schon,et al.  Nonidentical distribution of transferrin and ferric iron in human brain , 1988, Neuroscience.

[102]  R. Sahu,et al.  CSF zinc in Alzheimer's type dementia , 1988, Biological Psychiatry.

[103]  G. V. Van Hoesen,et al.  Perforant pathway changes and the memory impairment of Alzheimer's disease , 1986, Annals of neurology.

[104]  B. Winblad,et al.  Memory Function and Brain Biochemistry in Normal Aging and in Senile Dementia , 1985, Annals of the New York Academy of Sciences.

[105]  T. Arendt,et al.  Correlation between cortical plaque count and neuronal loss in the nucleus basalis in Alzheimer's disease , 1984, Neuroscience Letters.

[106]  G. Glenner,et al.  Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .

[107]  RICHARD M. Smith.  Copper in the Developing Brain , 1983 .

[108]  L. Hershey,et al.  Cerebrospinal fluid trace element content in dementia , 1983, Neurology.

[109]  F. Licastro,et al.  Impaired peripheral zinc metabolism in patients with senile dementia of probable Alzheimer’s type as shown by low plasma concentrations of thymulin , 2007, Biological Trace Element Research.

[110]  G. Reynolds,et al.  Hippocampal tin, aluminum and zinc in Alzheimer's disease , 2004, Biometals.

[111]  P. Wong,et al.  Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease , 2003, Nature Medicine.

[112]  M. Wolfe.  The secretases of Alzheimer's disease. , 2003, Current topics in developmental biology.

[113]  D. Butterfield,et al.  Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists. , 2002, Journal of Alzheimer's disease : JAD.

[114]  B. Halliwell,et al.  Role of Free Radicals in the Neurodegenerative Diseases , 2001, Drugs & aging.

[115]  D. Butterfield,et al.  Vitamin Ε as an Antioxidant/Free Radical Scavenger Against Amyloid β-Peptide-Induced Oxidative Stress in Neocortical Synaptosomal Membranes and Hippocampal Neurons in Culture: Insights into Alzheimer's Disease , 1999 .

[116]  F. Jiménez-Jiménez,et al.  Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease , 1998, Journal of Neural Transmission.

[117]  Weiming Xia,et al.  Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice , 1997, Nature Medicine.

[118]  A. Bruce.  β-Amyloid toxicity in organotypic cultures : protection by EUK-8, a synthetic catalytic free radical scavenger , 1996 .

[119]  G. Multhaup.  Identification and regulation of the high affinity binding site of the Alzheimer's disease amyloid protein precursor (APP) to glycosaminoglycans. , 1994, Biochimie.

[120]  G. Mashour,et al.  Ceruloplasmin is increased in cerebrospinal fluid in Alzheimer's disease but not Parkinson's disease. , 1994, Alzheimer disease and associated disorders.

[121]  B. Winblad,et al.  Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease. , 1991, Journal of neural transmission. Parkinson's disease and dementia section.

[122]  J. Constantinidis.  Hypothesis Regarding Amyloid and Zinc in the Pathogenesis of Alzheimer Disease: Potential for Preventive Intervention , 1991, Alzheimer disease and associated disorders.

[123]  C. Frederickson.  Neurobiology of zinc and zinc-containing neurons. , 1989, International review of neurobiology.

[124]  Robert Creeley,et al.  St. Martin's , 1971 .